Evidence map›Paper›PMID 39091626›Full record

ArticleOpen life sciences2024

Evaluation of the activity of antimicrobial peptides against bacterial vaginosis.

Xuning Kang, Ting Zhao, Yuzhu Song, Jinyang Zhang, Tao Yuan, Qinqin Han

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open life sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuning KangCollege of Life Science and Technology & Affiliated Hospital, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.
Ting ZhaoCollege of Life Science and Technology & Affiliated Hospital, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.
Yuzhu SongCollege of Life Science and Technology & Affiliated Hospital, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.
Jinyang ZhangCollege of Life Science and Technology & Affiliated Hospital, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.
Tao YuanCollege of Life Science and Technology & Affiliated Hospital, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.
Qinqin HanCollege of Life Science and Technology & Affiliated Hospital, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New drugs for the treatment of bacterial vaginosis (BV) are yet to be developed due to concerns that they may contribute to the increase in antibiotic resistance in BV. Antimicrobial peptides (AMPs) are one of the most promising options for next-generation antibiotics. In this study, we investigated the bacteriostatic activity of the AMPs Pexiganan, plectasin, melittin, and cathelicidin-DM against Gram-negative and Gram-positive bacteria both

Indexed as

antimicrobial peptidesgram-negative bacteriagram-positive bacteria

Identifiers

PMID39091626
PMCPMC11292031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.